Are nurses using catheter lock solutions correctly? new study investigates
NCT ID NCT07259421
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will survey how taurolidine lock solutions are actually given to patients with a PICC line who need nutrition through a vein. Researchers will check if nurses follow the recommended steps and compare what is prescribed to what is administered. The goal is to spot any gaps in practice and improve safety for these patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
taurolidine lock solution
What this could lead to
If this study reveals common mistakes, it could lead to better training and safer use of taurolidine lock solutions, reducing infections in PICC patients.
What could go wrong
This is a small, observational survey (45 participants) at a single hospital. It only describes current practices, not testing a new treatment, so it won't directly change patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TAUROLIDINE LOCK SOLUTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••